OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
SCZC Santa Cruz County Bank
VSYM View Systems Inc
KO Coca-Cola Co
LAKE Lakeland Industries Inc
LAIX LAIX Inc
LADR Ladder Capital Corp
LAD Lithia Motors Inc
LACQ Leisure Acquisition Corp
LAC Lithium Americas Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing.

Closing Price
$9.65
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
796,687
0

Display:

Providers:

UpdateCancel
6 providers
Today's News, June 14, 2021
OraSure and the Will Rodgers Liver Health Foundation to Heighten Awareness Around the Importance of Hepatitis C Testing

OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it is collaborating with the Will Rodgers Liver Health Foundation to increase awareness around the role Hepatitis C (HCV) plays in chronic liver disease and promoting testing services...(Globe Newswire)

June 11, 2021
Integral Molecular's Rapid SARS-CoV-2 Epitope Mapping Supports Regulatory Requirements for the Development of Therapeutic Antibodies Effective Against Viral Variants

At the forefront of the fight against COVID-19, Integral Molecular's rapid Epitope Mapping technology is being used to pinpoint precise binding sites of therapeutic SARS-CoV-2 antibodies under development and can help determine their effectiveness...(PR Newswire)

June 07, 2021
OraSure Technologies Receives Three Emergency Use Authorizations for its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use

OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its COVID-19 rapid antigen tests, which the Company is branding as InteliSwab(TM)...(Globe Newswire)

May 28, 2021
OraSure Technologies to Present at the Jefferies Virtual Healthcare Conference

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a...(Globe Newswire)

May 18, 2021
OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a...(Globe Newswire)

May 17, 2021
OraSure Technologies Appoints Scott Gleason As Senior Vice President Investor Relations and Corporate Communications

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Scott Gleason has been appointed Senior Vice President...(Globe Newswire)

May 12, 2021
OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 18, 2021

OraSure Technologies, Inc. (NASDAQ: OSUR), announced that its 2021 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern (7:00 a.m. Pacific) on Tuesday, May 18, 2021. (Globe Newswire)

May 10, 2021
Insignia and Partners Support CDC Demonstration Project for Uptake of Self-test Kits for HIV

Insignia Federal Group, LLC, along with partners Building Healthy Online Communities (BHOC), Emory University, Keymind (a Division of Axiom Resource Management), and OraSure Technologies, Inc. (NASDAQ: OSUR), was selected by the Centers for Disease...(Globe Newswire)

May 05, 2021
OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update

First Quarter 2021 Net Revenues of $59 Million Increased 85% Over 2020, Driven by $27 Million in Sales of Sample Collection Devices for COVID-19 Molecular Testing EUA Application Submitted in Q1 to FDA for COVID-19 Rapid Antigen Test for Both...(Globe Newswire)

OraSure Technologies, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 5, 2021 / OraSure Technologies, Inc. (NASDAQ:OSUR) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 5:00 PM Eastern Time. (Accesswire)

April 30, 2021
OraSure Technologies to Hold 2021 First Quarter Earnings Conference Call Wednesday, May 5, 2021, 5:00 p.m. ET

OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 first quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 5, 2021. (Globe Newswire)

April 28, 2021
At-Home Testing Kits Market by Coronavirus-COVID19 Impact Analysis with Top Analysis Players | Abbott, ACON Laboratories, Inc., Rapikit, BTNX INC., bioLytical Laboratories Inc.

A new market study is released on Global At-Home Testing Kits Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. This At-Home Testing Kits...(Globe Newswire)

April 13, 2021
Serimmune Opens Enrollment for COVID-19 Immune Response Study

Serimmune, Inc., a leader in understanding the functional antibody repertoire's role in human disease, announced today that the company is enrolling 2,000 research participants in a study designed to understand the human immune response to...(PR Newswire)

April 08, 2021
Molecular Diagnostics Point of Care Market Size to Reach USD 4.84 Billion in 2027 | Increasing Prevalence of Infectious Diseases and Rising Demand for Diagnostics Point-Of-Care are Key Factors Driving Industry Growth, says Emergen Research

The global molecular diagnostics point of care market size is expected to reach USD 4.84 Billion in 2027 and register a robust revenue CAGR of 10.6% over the forecast period, according to latest analysis by Emergen Research. A primary factor...(Globe Newswire)

March 30, 2021
OraSure Technologies Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization

OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it has submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its COVID-19 rapid antigen test for both Prescription Home Use...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.